lobbying_activities: 2081106
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2081106 | 4ed51bd4-2074-4940-9336-2fa690e57660 | Q4 | KING & SPALDING LLP | 21632 | U.S. CHAMBER OF COMMERCE INSTITUTE FOR LEGAL REFORM | 2017 | fourth_quarter | TOR | Provisions in the Food, Drug & Cosmetic Act related to advertising involving drugs | Congressional Budget Office (CBO),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2018-01-22T10:10:35.397000-05:00 |